Cite
HARVARD Citation
Yamanishi, T. et al. (2019). A 52‐week multicenter randomized controlled study of the efficacy and safety of add‐on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study). LUTS. 11 (3), pp. 115-121. [Online].